Guy Lafleur Fund: New ambassadors and $10 M goal to accelerate cancer research
New ambassadors for the Guy Lafleur Fund
The CHUM Foundation is proud to announce that Martin Lafleur is teaming up with new brand ambassadors to promote the Guy Lafleur Fund. Martin, son of The Flower, will be supported by none other than Guy Carbonneau, former Habs player and head coach and member of the Hockey Hall of Fame, and Dary Laflamme, CEO of Boscus Canada Inc. Their wives—Angelica Viapiano, commercial and residential real estate broker at Remax Crystal, Line Boivin, founder and business manager and Marlène Castonguay, retired health care professional—have generously agreed to round out this dedicated team and push cancer research forward.
“It’s a great honour to get involved with the Guy Lafleur Fund,” says Guy Carbonneau. “Guy was an idol of mine, a real inspiration for me and my hockey career. I was privileged enough to stand by his side on and off the ice. Today, I am proud to carry on this great man’s mission.”
A new, ambitious goal: $10 M for cancer research
Launched in 2021, the Guy Lafleur Fund has so far raised $3.7 million toward its goal of $5 million. Its ambassadors are keenly aware of the ever-greater needs for cancer research funding, so they have chosen to be ambitious, raise their goal to $10 million and double down on the Fund’s support for personalized medicine. They are dreaming big and trust that the public will heed their call to support the cause that Guy Lafleur cared so deeply about: the fight against cancer.
Crucial donations for personalized medicine in oncology research
All donations to the Guy Lafleur Fund go directly to cancer research at the CHUM Research Centre, a cause that was near and dear to the hockey legend and remains so for Quebecers everywhere. Under Dr. Réjean Lapointe’s leadership, the Centre’s researchers, epidemiologists and clinicians have pooled their efforts to establish a personalized oncology care program.
“Thanks to the support of Guy Lafleur Fund donors, we’re empowering CHUM Research Centre teams to build a future where the words “incurable,” “after-effects” and “side effects” gradually become a thing of the past,” says Dary Laflamme.
Grants for innovative research projects in oncology
On December 9, 2024, the CHUM Research Centre’s personalized medicine program in oncology unveiled four promising research projects at an exclusive event, each receiving a grant of $250,000. These were the first four grants awarded by the Guy Lafleur Fund since its founding in 2021.
Learn more about the projects led by the CHUM Research Centre’s incredible researchers
